25th Orphan Drugs & Rare Diseases Global Congress 2027 Europe

The 25th Orphan Drugs & Rare Diseases Global Congress 2027 Europe is dedicated to the critical issues shaping the future of Orphan Drugs.

Key Topics

• Finding innovative and alternative ways in funding the development of Orphan Drugs
• What is Orphan Drugs’ role in sustainability of the Pharmaceutical Industry?
• What Do Developers Look for When Looking for an Outsourcing Partner?
• How commercially viable Is It to Engage in the Development of Orphan Drugs?
• Trends and Deal Structures in Licensing Agreements
• Coming Together in Developing Orphan Drugs and Crossing Borders
• Patient Access: How Can This Continue to Improve?
• How Can the Developer and the Patient Assist in the Evolution and Development of Orphan Drugs?
• What Do Insurance Companies Think About Orphan Drugs? Will They Make Modifications to Their Policies to Support Patients with Rare Diseases?

Who should Attend

Senior attendees with responsibilities in:

• Personalised Medicine
• Research and Development
• External R&D Innovation
• Regenerative Medicine
• Rare and Ultra-Rare Diseases
• Innovative Medicine
• Cell and Gene Therapy
• Therapeutic Are Lead
• Molecular Geneticist
• Translational Science
• Patient Advocacy Groups
• Program Management
• Public Affairs
• Patient Engagement
• Regulatory Affairs
• Medical Affairs
• Market Access
• Clinical Research Organizations
• Pricing and Reimbursement
• Managed and Early Access
• Commercial Development
• Health Economics Outcomes Research
• Product Specialist
• Investments and Funding
• Business Planning and Operations
• Global Strategic Services
• Academia
• Speciality Pharmacies